Form 4: Thermo Fisher Scientific Executive Gianluca Pettiti Reports Stock and Option Awards

Executive Vice President Gianluca Pettiti reports acquisition of stock and option awards from Thermo Fisher Scientific.

Summary

• Gianluca Pettiti, an Executive Vice President at Thermo Fisher Scientific, filed a Form 4 detailing changes in beneficial ownership.
• The report indicates the acquisition of 2,056 shares of common stock at $0, and 6,823 shares related to a performance-based restricted stock unit award also at $0.
• Pettiti also acquired options to buy 12,599 shares of common stock at an exercise price of $530.86.
• The performance-based restricted stock units vest in three tranches, with the final tranche subject to adjustment based on Thermo Fisher Scientific's total shareholder return compared to its peer group.
• The stock options vest in four equal annual installments beginning February 28, 2026.

Sentiment

Score: 7

Explanation: The document reflects standard executive compensation practices, indicating a stable and well-managed company. The performance-based components suggest a focus on long-term value creation.

Positives

• The vesting of performance-based restricted stock units suggests that the company has met certain performance criteria.
• The grant of stock options aligns the executive's interests with those of the shareholders.

Risks

• The value of the stock options is dependent on the future stock price of Thermo Fisher Scientific.
• The final tranche of the performance-based restricted stock units is subject to adjustment based on the company's performance relative to its peers.

Future Outlook

The vesting of the performance-based restricted stock units is contingent on the company's future performance, specifically its total shareholder return compared to its peer group.

Industry Context

Executive compensation packages often include stock options and restricted stock units to align management's interests with those of shareholders. The vesting schedules and performance-based criteria are common features designed to incentivize long-term value creation.

Comparison to Industry Standards

• Thermo Fisher Scientific's executive compensation practices, including the use of stock options and restricted stock units, are consistent with industry standards among large-cap companies.
• Companies like Danaher and Agilent Technologies also utilize similar equity-based compensation plans to incentivize their executives.
• The vesting schedules and performance metrics tied to these awards are generally in line with those observed in peer companies.

Stakeholder Impact

• The equity-based compensation aligns the executive's interests with those of the shareholders, potentially leading to increased shareholder value.
• Employees may be indirectly impacted by the executive's performance, which is tied to the company's overall success.

Key Dates